Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Names Sullivan Director, Ullrich Wins Cancer Research Award, Sheridan Joins HTG, and More

NEW YORK (GenomeWeb Daily News) – PerkinElmer has elected Patrick Sullivan to its board of directors. Sullivan is executive chairman of Hologic and he was president and CEO of Cytyc. He also worked in sales and marketing at Abbott Laboratories and he was consultant at McKinsey & Company.

Axel Ullrich, director of Molecular Biology at the Max Planck Institute of Biochemistry, has been awarded the Pezcoller Foundation-AACR International Award for Cancer Research. Ullrich won the award for his work in the translation of genomics discoveries into cancer therapeutics approaches.
Ullrich will receive a cash award of €75,000 ($113,000) at a ceremony in Trengo, Italy, in May and he will give an award lecture in San Diego in April.

GenomeQuest has hired Anthony Salerno to be VP of strategic business development. Salerno formerly was director of strategic business development at Agilent Technologies, and he formerly was founder and CEO of VectorObjects and managing director of BioDynamics Associates.

Progenika has appointed Gerald Sandler, a professor of pathology and medicine at Georgetown University’s Medical Center, to its scientific advisory board. Sandler directs transfusion medicine at Georgetown, and he formerly was associate VP and CMO of the American Red Cross Blood Services and medical director of the Red Cross’s Rare Blood Donor Registry and National Reference Laboratories.

PLoS Biology, an open-access journal published by the Public Library of Science, has named Jonathan Eisen to be the journal’s academic editor-in-chief. Eisen is a professor at the University of California, Davis, Genome Center and he is an editorial adviser for PLoS Biology and PLoS Computational Biology.

Jonathan Sheridan will take over the role of VP of commercial operations at High Throughput Genomics. Sheridan formerly was director of sales and corporate development at Epicentre Biotechnologies and regional product line leader at PerkinElmer’s Life and Analytical Sciences group. He will run the company’s new office in Madison, Wisc.

Bob Welch, who directed operations at the National Cancer Institute's Core Genotyping Facility, died last Saturday at the age of 35.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.